Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 1 (2004), Issue 4 (December)

1. Intergenomic consensus in multifactorial inheritance loci: the case of multiple sclerosis.
   Genes Immun, 5(8): 615-20. [Abstract] [Full-text]
2. Reduced expression of NO-sensitive guanylyl cyclase in reactive astrocytes of Alzheimer disease, Creutzfeldt-Jakob disease, and multiple sclerosis brains.
   Neurobiol Dis, 17(3): 462-72. [Abstract] [Full-text]
3. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.
   Brain Res Brain Res Rev, 46(3): 261-81. [Abstract] [Full-text]
4. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.
   J Neuroimaging, 15(1): 27-36. [Abstract] [Full-text]
5. The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis.
   J Health Psychol, 10(1): 163-73. [Abstract] [Full-text]
6. Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-beta1b.
   Cytokine, 29(1): 24-30. [Abstract] [Full-text]
7. Total knee replacement in patients with multiple sclerosis.
   Knee, 11(6): 485-7. [Abstract] [Full-text]
8. Interscan registration using navigator echoes.
   Magn Reson Med, 52(6): 1448-52. [Abstract] [Full-text]
9. Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain.
   Neuroepidemiology, 24(1): 70-5. [Abstract] [Full-text]
10. No major birth order effect on the risk of multiple sclerosis.
    Neuroepidemiology, 24(1): 38-41. [Abstract] [Full-text]
11. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity.
    Immunol Lett, 96(2): 195-201. [Abstract] [Full-text]
12. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Immunol Lett, 96(1): 11-26. [Abstract] [Full-text]
13. Color Doppler imaging in optic neuritis with multiple sclerosis.
    Graefes Arch Clin Exp Ophthalmol, 242(12): 990-4. [Abstract] [Full-text]
14. A case of multiple sclerosis with homonymous hemianopia examined by positron emission tomography.
    Jpn J Ophthalmol, 48(6): 591-3. [Abstract] [Full-text]
15. Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
    J Neurol, 251(11): 1329-39. [Abstract] [Full-text]
16. Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis.
    J Neurol, 251(11): 1297-303. [Abstract] [Full-text]
17. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
    Lancet, 364(9451): 2106-12. [Abstract] [Full-text]
18. Plasma osteopontin levels in multiple sclerosis.
    J Neuroimmunol, 158(1): 231-9. [Abstract] [Full-text]
19. Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS.
    J Neuroimmunol, 158(1): 222-30. [Abstract] [Full-text]
20. Multiple sclerosis: interferon-beta induces CD123(+)BDCA2- dendritic cells that produce IL-6 and IL-10 and have no enhanced type I interferon production.
    J Neuroimmunol, 158(1): 204-12. [Abstract] [Full-text]
21. Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.
    J Neuroimmunol, 158(1): 195-203. [Abstract] [Full-text]
22. Expression patterns of Group III metabotropic glutamate receptors mGluR4 and mGluR8 in multiple sclerosis lesions.
    J Neuroimmunol, 158(1): 182-90. [Abstract] [Full-text]
23. Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients.
    J Neuroimmunol, 158(1): 170-81. [Abstract] [Full-text]
24. Congenital adrenal hyperplasia and multiple sclerosis: is there an increased risk of multiple sclerosis in individuals with congenital adrenal hyperplasia?
    Arch Neurol, 61(12): 1953-5. [Abstract] [Full-text]
25. Ctla4 and multiple sclerosis in the Italian population.
    Exp Mol Pathol, 78(1): 55-7. [Abstract] [Full-text]
26. Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data.
    Acta Neurol Scand, 111(1): 42-7. [Abstract] [Full-text]
27. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
    Brain, 128: 29-34. [Abstract] [Full-text]
28. Neuropathology of white matter disease in Leber's hereditary optic neuropathy.
    Brain, 128: 35-41. [Abstract] [Full-text]
29. Quality of life and impairment in patients with multiple sclerosis.
    J Neurol Neurosurg Psychiatry, 76(1): 64-9. [Abstract] [Full-text]
30. A comparison of health utility measures for the evaluation of multiple sclerosis treatments.
    J Neurol Neurosurg Psychiatry, 76(1): 58-63. [Abstract] [Full-text]
31. The multiple sclerosis functional composite: different practice effects in the three test components.
    J Neurol Sci, 228(1): 71-4. [Abstract] [Full-text]
32. Genetic variants of Complex I in multiple sclerosis.
    J Neurol Sci, 228(1): 55-64. [Abstract] [Full-text]
33. Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients.
    Clin Exp Immunol, 139(1): 152-8. [Abstract] [Full-text]
34. Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis.
    Neuroradiology, 46(11): 906-15. [Abstract] [Full-text]
35. The meaning of fatigue for women with multiple sclerosis.
    J Adv Nurs, 49(1): 7-15. [Abstract] [Full-text]
36. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis.
    Cell Death Differ, 11: S181-92. [Abstract] [Full-text]
37. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease.
    Eur J Neurol, 12(1): 49-54. [Abstract] [Full-text]
38. CSF from MS patients can induce acute conduction block in the isolated optic nerve.
    Eur J Neurol, 12(1): 45-8. [Abstract] [Full-text]
39. A prospective study of the financial costs of multiple sclerosis at different stages of the disease.
    Eur J Neurol, 12(1): 31-9. [Abstract] [Full-text]
40. Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4-year follow-up study.
    Eur J Neurol, 12(1): 25-30. [Abstract] [Full-text]
41. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis.
    Med Hypotheses, 64(3): 608-18. [Abstract] [Full-text]
42. A possible link between multiple sclerosis and Creutzfeldt-Jakob disease based on clinical, genetic, pathological and immunological evidence involving Acinetobacter bacteria.
    Med Hypotheses, 64(3): 487-94. [Abstract] [Full-text]
43. Chronic Lyme borreliosis at the root of multiple sclerosis--is a cure with antibiotics attainable?
    Med Hypotheses, 64(3): 438-48. [Abstract] [Full-text]
44. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    Radiology, 234(1): 211-7. [Abstract] [Full-text]
45. Autologous haematopoietic-stem-cell transplantation for multiple sclerosis.
    Lancet Neurol, 4(1): 54-63. [Abstract] [Full-text]
46. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.
    Lancet Neurol, 4(1): 32-41. [Abstract] [Full-text]
47. Evolution of self-reactive IgG antibody repertoires in patients with relapsing-remitting multiple sclerosis.
    Immunol Lett, 97(1): 55-62. [Abstract] [Full-text]

© 2004-2010 Multiple Sclerosis Research Today. All Rights Reserved.